NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 231 filers reported holding NEVRO CORP in Q4 2020. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,052 | -11.6% | 2,292 | +16.9% | 0.00% | 0.0% |
| Q2 2023 | $49,849 | -29.7% | 1,961 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $70,890 | -15.6% | 1,961 | -7.6% | 0.00% | 0.0% |
| Q4 2022 | $84,031 | -15.0% | 2,122 | 0.0% | 0.00% | -20.0% |
| Q3 2022 | $98,885 | +6.3% | 2,122 | 0.0% | 0.01% | +25.0% |
| Q2 2022 | $93,007 | -39.4% | 2,122 | 0.0% | 0.00% | -20.0% |
| Q1 2022 | $153,484 | -79.2% | 2,122 | -76.7% | 0.01% | -50.0% |
| Q4 2021 | $739,521 | -30.3% | 9,122 | 0.0% | 0.01% | -33.3% |
| Q3 2021 | $1,061,618 | -32.6% | 9,122 | -3.9% | 0.02% | -31.8% |
| Q2 2021 | $1,574,176 | +21.6% | 9,495 | +2.3% | 0.02% | +15.8% |
| Q1 2021 | $1,294,979 | -22.2% | 9,283 | -3.5% | 0.02% | -24.0% |
| Q4 2020 | $1,665,395 | +23.1% | 9,621 | -0.9% | 0.02% | +4.2% |
| Q3 2020 | $1,352,882 | +10.9% | 9,712 | -4.9% | 0.02% | +9.1% |
| Q2 2020 | $1,219,908 | +35.5% | 10,211 | +13.4% | 0.02% | +15.8% |
| Q1 2020 | $900,120 | -17.1% | 9,003 | -2.5% | 0.02% | +5.6% |
| Q4 2019 | $1,085,599 | +30.8% | 9,236 | -4.3% | 0.02% | +28.6% |
| Q3 2019 | $829,696 | +37.9% | 9,651 | +4.0% | 0.01% | +40.0% |
| Q2 2019 | $601,882 | +3.7% | 9,284 | 0.0% | 0.01% | -9.1% |
| Q1 2019 | $580,343 | +60.7% | 9,284 | 0.0% | 0.01% | +57.1% |
| Q4 2018 | $361,055 | -31.8% | 9,284 | 0.0% | 0.01% | -22.2% |
| Q3 2018 | $529,188 | -99.9% | 9,284 | 0.0% | 0.01% | -25.0% |
| Q2 2018 | $741,328,000 | -6.0% | 9,284 | +2.0% | 0.01% | +9.1% |
| Q1 2018 | $788,784,000 | +125903.8% | 9,101 | +0.3% | 0.01% | +37.5% |
| Q4 2017 | $626,000 | -68.0% | 9,073 | -57.8% | 0.01% | -33.3% |
| Q3 2017 | $1,954,000 | +39.0% | 21,498 | +13.8% | 0.01% | +20.0% |
| Q2 2017 | $1,406,000 | -10.4% | 18,894 | +12.8% | 0.01% | -9.1% |
| Q1 2017 | $1,569,000 | +25.5% | 16,749 | -2.6% | 0.01% | +22.2% |
| Q4 2016 | $1,250,000 | -30.4% | 17,198 | 0.0% | 0.01% | -30.8% |
| Q3 2016 | $1,795,000 | +39.1% | 17,198 | -1.7% | 0.01% | +30.0% |
| Q2 2016 | $1,290,000 | +89.1% | 17,489 | +44.4% | 0.01% | +100.0% |
| Q1 2016 | $682,000 | -15.0% | 12,115 | +2.0% | 0.01% | -16.7% |
| Q4 2015 | $802,000 | +56.6% | 11,875 | +7.5% | 0.01% | +50.0% |
| Q3 2015 | $512,000 | -11.3% | 11,045 | +2.9% | 0.00% | 0.0% |
| Q2 2015 | $577,000 | +76.5% | 10,732 | +26.8% | 0.00% | +100.0% |
| Q4 2014 | $327,000 | – | 8,465 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tiger Eye Capital LLC | 239,122 | $41,392,000 | 8.25% |
| Integral Health Asset Management, LLC | 88,000 | $15,233,000 | 4.53% |
| Iron Triangle Partners LP | 168,761 | $29,213,000 | 3.79% |
| Eos Focused Equity Management, L.P. | 14,002 | $2,424,000 | 2.37% |
| PFM Health Sciences, LP | 311,940 | $53,997,000 | 1.90% |
| Perceptive Advisors | 977,565 | $169,217,000 | 1.82% |
| Rock Springs Capital Management LP | 395,000 | $68,375,000 | 1.45% |
| Lisanti Capital Growth, LLC | 54,302 | $9,400,000 | 1.30% |
| HealthCor Management, L.P. | 156,046 | $27,012,000 | 1.04% |
| FRED ALGER MANAGEMENT, LLC | 2,136,612 | $369,848,000 | 0.96% |